Category: Featured

2024 WATCH LIST

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

Editor | Curator - April 3, 2024

ALCOHOL

1000 Days Without Alcohol: Here’s What Happened

Editor | Curator - February 7, 2024

CLINICS

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

Editor | Curator - January 30, 2024

Psychedelic Universe 9-20-2021

INVESTORS Editor | Curator - August 3, 2021

UPDATED WEEKLY - 10/15/2021 Alphabetical A-W SymbolCompany NameLast PriceVolumeMarket CapAvg Vol (3m)52-Wk High52-Wk LowExchangeShares OutATAIAtai Life Sciences N.V.12.97143,9052.008B292,61022.9112.12NGM154.82MAWKN.NEAwakn Life...

View Post

Adding Ehave (EHVVF) to Psychedelic Stock Watch List.

CLINICAL TRIALS Editor | Curator - August 3, 2021

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low.Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical Trial With Mycotopia Therapies and PsyBioMed.Launching...

View Post

Able Partners

INVESTORS Editor | Curator - August 2, 2021

Able Partners Venture Capital People:Lisa Blau (Partner)Alison Ryu (Managing Director)Amanda Eilian (Partner) Location:New York, New York, USA

View Post

NovaMind (CSE:NM, OTC:NVMDF) Presentation Deck.

CLINICS Editor | Curator - August 1, 2021

Presentation Deck LIVE QUOTE Canadian Chart Decks contain...

View Post

Cybin (CLXPF CYBN) Banks $30 Million Overnight.

PSYCH STOCK NEWS Editor | Curator - July 28, 2021

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares. LIVE QUOTE

View Post

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

RESEARCH Editor | Curator - July 27, 2021

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT

View Post

Incredible Ibogaine Psychedelic’s Testimonial.

TESTIMONIALS Editor | Curator - July 27, 2021

TIME MAGAZINE: Marcus Capone, Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction Scroll down...

View Post

Psychedelic IPOs Build Momentum (PitchBook).

PSYCH STOCK NEWS Editor | Curator - July 18, 2021

Psychedelic IPOs build momentum as Atai Life Sciences goes public PITCHBOOK Making its Wall Street debut, Peter Thiel-backed Atai Life Sciences has become the third biotech...

View Post

1...91011 Page 10 of 11